Literature DB >> 29238844

Cardiomyokines from the heart.

Ayano Chiba1, Haruko Watanabe-Takano1, Takahiro Miyazaki1, Naoki Mochizuki2,3.   

Abstract

The heart is regarded as an endocrine organ as well as a pump for circulation, since atrial natriuretic peptide (ANP) and brain natriuretic peptide (BNP) were discovered in cardiomyocytes to be secreted as hormones. Both ANP and BNP bind to their receptors expressed on remote organs, such as kidneys and blood vessels; therefore, the heart controls the circulation by pumping blood and by secreting endocrine peptides. Cardiomyocytes secrete other peptides besides natriuretic peptides. Although most of such cardiomyocyte-derived peptides act on the heart in autocrine/paracrine fashions, several peptides target remote organs. In this review, to overview current knowledge of endocrine properties of the heart, we focus on cardiomyocyte-derived peptides (cardiomyokines) that act on the remote organs as well as the heart. Cardiomyokines act on remote organs to regulate cardiovascular homeostasis, systemic metabolism, and inflammation. Therefore, through its endocrine function, the heart can maintain physiological conditions and prevent organ damage under pathological conditions.

Entities:  

Keywords:  CHGA; ET1; FGF21; FSTL1; sPLA2

Mesh:

Substances:

Year:  2017        PMID: 29238844     DOI: 10.1007/s00018-017-2723-6

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  180 in total

1.  Effect of atrial natriuretic peptide and cyclic GMP phosphodiesterase inhibition on collagen synthesis by adult cardiac fibroblasts.

Authors:  J Redondo; J E Bishop; M R Wilkins
Journal:  Br J Pharmacol       Date:  1998-08       Impact factor: 8.739

2.  Endothelin-1 is involved in mechanical stress-induced cardiomyocyte hypertrophy.

Authors:  T Yamazaki; I Komuro; S Kudoh; Y Zou; I Shiojima; Y Hiroi; T Mizuno; K Maemura; H Kurihara; R Aikawa; H Takano; Y Yazaki
Journal:  J Biol Chem       Date:  1996-02-09       Impact factor: 5.157

3.  DIP2 disco-interacting protein 2 homolog A (Drosophila) is a candidate receptor for follistatin-related protein/follistatin-like 1--analysis of their binding with TGF-β superfamily proteins.

Authors:  Masao Tanaka; Kosaku Murakami; Shoichi Ozaki; Yoshitaka Imura; Xiao-Peng Tong; Takuo Watanabe; Toshioki Sawaki; Takafumi Kawanami; Daisuke Kawabata; Takao Fujii; Takashi Usui; Yasufumi Masaki; Toshihiro Fukushima; Zhe-Xiong Jin; Hisanori Umehara; Tsuneyo Mimori
Journal:  FEBS J       Date:  2010-09-22       Impact factor: 5.542

4.  Plasma brain natriuretic peptide is a biochemical marker for the prediction of progressive ventricular remodeling after acute myocardial infarction.

Authors:  N Nagaya; T Nishikimi; Y Goto; Y Miyao; Y Kobayashi; I Morii; S Daikoku; T Matsumoto; S Miyazaki; H Matsuoka; S Takishita; K Kangawa; H Matsuo; H Nonogi
Journal:  Am Heart J       Date:  1998-01       Impact factor: 4.749

Review 5.  Atrial natriuretic peptide in hypoxia.

Authors:  Yiu-Fai Chen
Journal:  Peptides       Date:  2005-04-18       Impact factor: 3.750

6.  Mice with cardiomyocyte-specific disruption of the endothelin-1 gene are resistant to hyperthyroid cardiac hypertrophy.

Authors:  Ralph V Shohet; Yaz Y Kisanuki; Xiao-Song Zhao; Zakir Siddiquee; Fatima Franco; Masashi Yanagisawa
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-05       Impact factor: 11.205

7.  Genetic deletion of myostatin from the heart prevents skeletal muscle atrophy in heart failure.

Authors:  Joerg Heineke; Mannix Auger-Messier; Jian Xu; Michelle Sargent; Allen York; Stephen Welle; Jeffery D Molkentin
Journal:  Circulation       Date:  2010-01-11       Impact factor: 29.690

8.  Aerobic exercise training improves atrial natriuretic peptide and catecholamine-mediated lipolysis in obese women with polycystic ovary syndrome.

Authors:  Cedric Moro; Magdalena Pasarica; Karen Elkind-Hirsch; Leanne M Redman
Journal:  J Clin Endocrinol Metab       Date:  2009-04-14       Impact factor: 5.958

9.  Natriuretic peptides enhance the oxidative capacity of human skeletal muscle.

Authors:  Stefan Engeli; Andreas L Birkenfeld; Pierre-Marie Badin; Virginie Bourlier; Katie Louche; Nathalie Viguerie; Claire Thalamas; Emilie Montastier; Dominique Larrouy; Isabelle Harant; Isabelle de Glisezinski; Stefanie Lieske; Julia Reinke; Bibiana Beckmann; Dominique Langin; Jens Jordan; Cedric Moro
Journal:  J Clin Invest       Date:  2012-11-01       Impact factor: 14.808

10.  Novel insights into the cardio-protective effects of FGF21 in lean and obese rat hearts.

Authors:  Vanlata Patel; Raghu Adya; Jing Chen; Manjunath Ramanjaneya; Muhammad F Bari; Sunil K Bhudia; Edward W Hillhouse; Bee K Tan; Harpal S Randeva
Journal:  PLoS One       Date:  2014-02-03       Impact factor: 3.240

View more
  7 in total

1.  FSTL1 promotes growth and metastasis in gastric cancer by activating AKT related pathway and predicts poor survival.

Authors:  Mengjie Wu; Yongfeng Ding; Nan Wu; Junjie Jiang; Yingying Huang; Fanyu Zhang; Haiyong Wang; Quan Zhou; Yan Yang; Wei Zhuo; Lisong Teng
Journal:  Am J Cancer Res       Date:  2021-03-01       Impact factor: 6.166

2.  Associations among circulating levels of follistatin-like 1, clinical parameters, and cardiovascular events in patients undergoing elective percutaneous coronary intervention with drug-eluting stents.

Authors:  Tatsuro Aikawa; Kazunori Shimada; Katsumi Miyauchi; Tetsuro Miyazaki; Eiryu Sai; Shohei Ouchi; Tomoyasu Kadoguchi; Mitsuhiro Kunimoto; Yusuke Joki; Tomotaka Dohi; Shinya Okazaki; Kikuo Isoda; Koji Ohashi; Toyoaki Murohara; Noriyuki Ouchi; Hiroyuki Daida
Journal:  PLoS One       Date:  2019-04-29       Impact factor: 3.240

Review 3.  The Endocrine Function of the Heart: Physiology and Involvements of Natriuretic Peptides and Cyclic Nucleotide Phosphodiesterases in Heart Failure.

Authors:  Claire Lugnier; Alain Meyer; Anne Charloux; Emmanuel Andrès; Bernard Gény; Samy Talha
Journal:  J Clin Med       Date:  2019-10-21       Impact factor: 4.241

4.  Follistatin-like 1 promotes proliferation of matured human hypoxic iPSC-cardiomyocytes and is secreted by cardiac fibroblasts.

Authors:  Marijn C Peters; Sofia Di Martino; Thomas Boelens; Jiabin Qin; Alain van Mil; Pieter A Doevendans; Steven A J Chamuleau; Joost P G Sluijter; Klaus Neef
Journal:  Mol Ther Methods Clin Dev       Date:  2022-02-23       Impact factor: 6.698

5.  Clinical value of NT-proBNP measurements in assessing patients in the pediatric intensive care unit.

Authors:  Fang Liu; Xiaoli Luo; Xiuqi Chen; Zhenhao Lu; Dan Wei; Zhiyong Yang
Journal:  Transl Pediatr       Date:  2021-05

6.  Cardiomyocyte Contractility and Autophagy in a Premature Senescence Model of Cardiac Aging.

Authors:  Steffen Häseli; Stefanie Deubel; Tobias Jung; Tilman Grune; Christiane Ott
Journal:  Oxid Med Cell Longev       Date:  2020-04-14       Impact factor: 6.543

7.  Crosstalk between cardiomyocytes and noncardiomyocytes is essential to prevent cardiomyocyte apoptosis induced by proteasome inhibition.

Authors:  Fang Guo; Chen-Chen Zhang; Xi-Hui Yin; Ting Li; Cheng-Hu Fang; Xi-Biao He
Journal:  Cell Death Dis       Date:  2020-09-19       Impact factor: 8.469

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.